ARCHIVES

In Multi-Site Phase I Studies, No Investigator Sees All Toxicities

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Clinical Trials

December 29, 2006

Radiation, Tamoxifen After Surgery Reduce Breast Cancer Occurrence

March 25, 2011

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996

Immunoassays For Isoenzymes

April 15, 1983

FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible

May 20, 1988

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013